Schedule 13G ownership disclosure

Edgewise Therapeutics Inc

Security class unavailable · CUSIP: 28036F105

Event date: 2022-08-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-091290
Form type
SC 13G/A
Filer
Edgewise Therapeutics, Inc.
CIK
CIK 1710072
Filed
Aug 15, 2022
Reporting period
Aug 15, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub